Ed Arce

Stock Analyst at WestPark Capital

(3.77)
# 700
Out of 5,148 analysts
376
Total ratings
46.04%
Success rate
9.69%
Average return

Stocks Rated by Ed Arce

Enanta Pharmaceuticals
Sep 30, 2025
Maintains: Buy
Price Target: $24$28
Current: $14.51
Upside: +92.97%
Travere Therapeutics
Jun 11, 2025
Assumes: Buy
Price Target: $30
Current: $29.53
Upside: +1.59%
MetaVia
Apr 16, 2025
Reiterates: Buy
Price Target: $132
Current: $1.53
Upside: +8,527.45%
Unicycive Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $75
Current: $6.99
Upside: +972.96%
Arcturus Therapeutics Holdings
Apr 10, 2025
Reiterates: Buy
Price Target: $60
Current: $8.35
Upside: +618.56%
Akebia Therapeutics
Apr 4, 2025
Reiterates: Buy
Price Target: $7.5
Current: $1.26
Upside: +495.24%
Inventiva
Apr 2, 2025
Reiterates: Buy
Price Target: $13
Current: $6.29
Upside: +106.68%
Galectin Therapeutics
Apr 2, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.07
Upside: -
Talphera
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $0.91
Upside: +558.04%
Aligos Therapeutics
Mar 31, 2025
Reiterates: Buy
Price Target: $70
Current: $6.97
Upside: +905.03%
Reiterates: Neutral
Price Target: n/a
Current: $29.68
Upside: -
Reiterates: Buy
Price Target: $240
Current: $1.53
Upside: +15,586.27%
Reiterates: Neutral
Price Target: n/a
Current: $1.27
Upside: -
Reiterates: Buy
Price Target: $32
Current: $5.72
Upside: +459.44%
Maintains: Buy
Price Target: $66$72
Current: $90.09
Upside: -20.08%
Maintains: Buy
Price Target: $400$405
Current: $435.62
Upside: -7.03%
Reiterates: Neutral
Price Target: $5.5
Current: $6.47
Upside: -14.99%
Reiterates: Buy
Price Target: $95
Current: $23.02
Upside: +312.68%
Reiterates: Buy
Price Target: $5
Current: $4.67
Upside: +7.07%
Reiterates: Buy
Price Target: $48
Current: $32.83
Upside: +46.21%
Reiterates: Neutral
Price Target: $7.5
Current: $42.03
Upside: -82.16%
Reiterates: Buy
Price Target: $5
Current: $0.28
Upside: +1,670.54%
Reiterates: Buy
Price Target: $13
Current: $14.21
Upside: -8.52%
Reiterates: Buy
Price Target: $25
Current: $40.42
Upside: -38.15%
Downgrades: Neutral
Price Target: n/a
Current: $0.62
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $16.19
Upside: -
Assumes: Buy
Price Target: $7
Current: $33.34
Upside: -79.00%
Initiates: Buy
Price Target: $21
Current: $41.60
Upside: -49.52%
Downgrades: Neutral
Price Target: n/a
Current: $4.87
Upside: -